Lyell
Highly Engaged Employees
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
201 Haskins Way, South San Francisco, Ca...Phone Number
(650) 695-0677Website
www.lyell.comRevenue
<$5 MillionStock Symbol
LYELIndustry
About Lyell
Lyell Immunopharma, Inc., operating as Lyell, is a clinical-stage biotechnology company dedicated to developing next-generation cell therapies for patients with cancer. The organization specializes in advancing innovative chimeric antigen receptor T-cell therapies and related cellular immunotherapies designed to improve treatment outcomes for individuals with hematologic malignancies and solid tumors. The company's scientific mission centers on overcoming the biological limitations that reduce the effectiveness and durability of conventional cell therapies, thereby expanding the potential of engineered immune cells to provide long-lasting clinical benefit for patients with difficult-to-treat cancers.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: LYELShow moreLyell Org Chart
Compare Similar Companies to Lyell
Compare insights from companies similar to Lyell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lyell Tech Stack
A closer look at the technologies used by Lyell
Top Business Services Companies
Frequently Asked Questions Regarding Lyell
Sign Up For FreeTo access detailed company insights
Lyell Immunopharma, Inc., operating as Lyell, is a clinical-stage biotechnology company dedicated to developing next-generation cell therapies for patients with cancer. The organization specializes in advancing innovative chimeric antigen receptor T-cell therapies and related cellular immunotherapies designed to improve treatment outcomes for indiv... Read More

